Monday, May 23, 2011

A sad reading on cancer research, but is this still the current state of things?

I chanced upon an article here, which probably gotten its source of information from here.

This saddens me. This is an area of research that I wanted to do - cancer drug discovery using computer simulations. Anyhow, reading this article saddens me because it did reveal the capitalistic mindset of the 'real world'. Though, this is the nature of the 'real world' from a research company point of view, I am wonder are government bodies also doing something on this - i.e. capitalize on the research done and allow the public to benefit from it?

Extracting from the article (italics by me):

The DCA compound is not patented and not owned by any pharmaceutical company, and, therefore, would likely be an inexpensive drug to administer, says Michelakis, the Canada Research Chair in Pulmonary Hypertension and Director of the Pulmonary Hypertension Program with Capital Health, one of Canada's largest health authorities.

However, as DCA is not patented, Michelakis is concerned that it may be difficult to find funding from private investors to test DCA in clinical trials. He is grateful for the support he has already received from publicly funded agencies, such as the Canadian Institutes for Health Research (CIHR), and he is hopeful such support will continue and allow him to conduct clinical trials of DCA on cancer patients.

At the end, our research should drive to save lives, that's why we studied and worked so hard in research. It has a social responsibility component.

No comments: